GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Gross Profit

Labiana Health (XMAD:LAB) Gross Profit : €39.70 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Gross Profit?

Labiana Health's gross profit for the six months ended in Jun. 2024 was €22.55 Mil. Labiana Health's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was €39.70 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Labiana Health's gross profit for the six months ended in Jun. 2024 was €22.55 Mil. Labiana Health's Revenue for the six months ended in Jun. 2024 was €35.09 Mil. Therefore, Labiana Health's Gross Margin % for the quarter that ended in Jun. 2024 was 64.27%.

Labiana Health had a gross margin of 64.27% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 4 years, the highest Gross Margin % of Labiana Health was 61.45%. The lowest was 56.41%. And the median was 58.80%.


Labiana Health Gross Profit Historical Data

The historical data trend for Labiana Health's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Gross Profit Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
34.04 35.00 32.63 34.34

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial 18.24 14.40 17.19 17.15 22.55

Competitive Comparison of Labiana Health's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Gross Profit distribution charts can be found below:

* The bar in red indicates where Labiana Health's Gross Profit falls into.



Labiana Health Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Labiana Health's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=58.462 - 24.123
=34.34

Labiana Health's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=35.089 - 12.539
=22.55

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €39.70 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Labiana Health's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=22.55 / 35.089
=64.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Labiana Health  (XMAD:LAB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Labiana Health had a gross margin of 64.27% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Labiana Health Gross Profit Related Terms

Thank you for viewing the detailed overview of Labiana Health's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.